Evidence map›Paper›PMID 41899277›Full record

ArticleJournal of clinical medicine2026

Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.

Sedat Yıldız, Hacer Demir, Talha Özüdoğru, Damla Günenç, Zeynep Sıla Gökdere, Hayati Arvas, Zuhat Urakçı, Seda Jeral Evinç, Özkan Alan, Rumeysa Çolak and 31 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Sedat YıldızDepartment of Medical Oncology, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Turkey.ORCID 0000-0002-3817-8934
Hacer DemirDepartment of Medical Oncology, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Turkey.
Talha ÖzüdoğruDepartment of Medical Oncology, Faculty of Medicine, Ege University, İzmir 35100, Turkey.ORCID 0000-0002-5927-8387
Damla GünençDepartment of Medical Oncology, Faculty of Medicine, Ege University, İzmir 35100, Turkey.ORCID 0000-0002-7592-2021
Zeynep Sıla GökdereDepartment of Medical Oncology, Faculty of Medicine, Ege University, İzmir 35100, Turkey.ORCID 0000-0002-8868-988X
Hayati ArvasDepartment of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakır 21280, Turkey.ORCID 0000-0003-2215-5567
Zuhat UrakçıDepartment of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakır 21280, Turkey.
Seda Jeral EvinçDepartment of Medical Oncology, Cerrahpaşa Faculty of Medicine, Istanbul University, Istanbul 34452, Turkey.ORCID 0000-0002-6594-1712
Özkan AlanDepartment of Medical Oncology, Cerrahpaşa Faculty of Medicine, Istanbul University, Istanbul 34452, Turkey.ORCID 0000-0002-6635-2012
Rumeysa ÇolakDepartment of Medical Oncology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul 34147, Turkey.ORCID 0000-0002-3867-0793
Mesut YılmazDepartment of Medical Oncology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul 34147, Turkey.ORCID 0000-0003-1466-3887
Esra AşıkDepartment of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon 61080, Turkey.ORCID 0000-0003-3030-2475
Atila YıldırımDepartment of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon 61080, Turkey.ORCID 0000-0002-6067-5646
Ali Kaan GürenDepartment of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul 34854, Turkey.ORCID 0000-0002-3562-5006
Osman KöstekDepartment of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul 34854, Turkey.ORCID 0000-0002-1901-5603
Berkan KarabuğaDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara 06200, Turkey.ORCID 0000-0001-5357-7610
Öztürk AteşDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara 06200, Turkey.ORCID 0000-0003-0182-3933
Canberk ŞencanDepartment of Medical Oncology, Faculty of Medicine, Dokuz Eylül University, İzmir 35330, Turkey.
Tuğba YavuzşenDepartment of Medical Oncology, Faculty of Medicine, Dokuz Eylül University, İzmir 35330, Turkey.ORCID 0000-0001-9375-8133
Şuheda Ataş İpekDepartment of Medical Oncology, Faculty of Medicine, Çukurova University, Adana 01790, Turkey.ORCID 0000-0003-1377-0488
İsmail Oğuz KaraDepartment of Medical Oncology, Faculty of Medicine, Çukurova University, Adana 01790, Turkey.
Teoman ŞakalarDepartment of Medical Oncology, Faculty of Medicine, Kahramanmaraş Sütçü İmam University, Kahramanmaraş 46050, Turkey.
Ahmet Cebeli GökayDepartment of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep 27850, Turkey.
Havva Yeşil ÇınkırDepartment of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep 27850, Turkey.ORCID 0000-0002-7870-8741
Ahmet Kürşad DişliDepartment of Medical Oncology, Erciyes University, Kayseri 38280, Turkey.
Mevlüde İnançDepartment of Medical Oncology, Erciyes University, Kayseri 38280, Turkey.
Olçun Ümit ÜnalDepartment of Medical Oncology, İzmir City Hospital, İzmir 35540, Turkey.
Emre YılmazDepartment of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya 54290, Turkey.
İlhan HacıbekiroğluDepartment of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya 54290, Turkey.
Sait KitaplıDepartment of Medical Oncology, Faculty of Medicine, Muğla Sıtkı Koçman University, Muğla 48000, Turkey.
Özgür TanrıverdiDepartment of Medical Oncology, Faculty of Medicine, Muğla Sıtkı Koçman University, Muğla 48000, Turkey.
Elif ŞahinDepartment of Medical Oncology, Kocaeli City Hospital, Kocaeli 41060, Turkey.ORCID 0000-0002-1976-3951
Muhammed Fatih SağıroğluDepartment of Medical Oncology, Antalya City Hospital, Antalya 07080, Turkey.
Pembegül YumuştutanDepartment of Medical Oncology, Ümraniye Training and Research Hospital, Istanbul 34764, Turkey.
Seray SarayDepartment of Medical Oncology, Balıkesir Atatürk City Hospital, Balıkesir 10100, Turkey.ORCID 0000-0001-5916-6265
Selahattin ÇelikDepartment of Medical Oncology, Etlik City Hospital, Ankara 06170, Turkey.ORCID 0000-0002-5678-2633
Hayriye ŞahinliDepartment of Medical Oncology, Etlik City Hospital, Ankara 06170, Turkey.ORCID 0000-0002-1561-9346
Azer GökmenDepartment of Medical Oncology, Van Yüzüncü Yıl University, Van 65090, Turkey.
Gizem Bakır KahveciDepartment of Medical Oncology, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.
Didem DivriklioğluDepartment of Medical Oncology, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.ORCID 0000-0001-9956-3900
Saadettin KılıçkapDepartment of Medical Oncology, LIV Hospital Ankara, Ankara 06680, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

medullary thyroid carcinomatyrosine kinase inhibitor

Identifiers

PMID41899277
PMCPMC13026659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.